Position in PCRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,811,454
-$2,608,282 QoQ
Shares Held
478,383
-7.7% QoQ
Ownership
1.22%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026WELLINGTON MANAGEMENT GROUP LLP holds $3,311,744,758 across 31 Drug Manufacturers - Specialty & Generic names. PCRX ranks #11 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
2,264,247 | $1,342,653,181 | |
| 2 | ZTS |
Zoetis Inc.
|
10,150,096 | $1,199,842,846 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,251,828 | $218,425,057 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
1,389,539 | $183,057,866 | |
| 5 | ALKS |
Alkermes plc.
|
2,970,166 | $105,025,067 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
3,035,856 | $72,648,032 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
768,850 | $58,317,270 | |
| 8 | HLN |
Haleon plc
|
4,828,648 | $48,334,765 |
All Filings in PCRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,811,454 | 478,383 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $13,419,736 | 518,537 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $13,619,830 | 528,515 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $13,039,884 | 545,602 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $13,347,679 | 537,130 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $8,858,397 | 470,191 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $6,842,465 | 454,649 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $13,936,929 | 487,135 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,568,237 | 293,232 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $11,053,425 | 327,606 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $9,630,758 | 313,910 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $17,524,613 | 437,350 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $15,457,927 | 378,778 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $25,600,822 | 663,062 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $50,906,445 | 957,068 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $43,316,258 | 742,989 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $51,620,176 | 676,365 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,271,769 | 70,995 | Shares | Defined | 2022-02-11 | |
| 2020-12-31 | $21,905,688 | 366,071 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $22,464,078 | 373,654 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $19,650,539 | 374,510 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||